- Is It Possible To Compare PSA Recurrence-Free Survival After Surgery And Radiotherapy By : Health News
A lack of randomized trials for radiotherapy (XRT) and radical prostatectomy (RP) make it difficult for patients to compare outcomes. Biochemical recurrence (BR) after RP is defined as an initial level of 0.2ng/ml or greater......... - The Impact Of Treatment Choice For Localized Prostate Cancer On Response To Phosphodiesterase Inhibi By : Health News
UroToday.com - In the March, 2008 issue of the Journal of Urology, Dr. Lee and colleagues report an analysis that the choice of radical prostatectomy (RP) or radiotherapy......... - Study Finds Improvement In The Care Of Children With Cancer At The End Of Life By : Health News
Expanded use of palliative care services is associated with enhanced communications between families and caregivers, improved symptoms management......... - Loopholes putting thousands of women at risk of death from breast cancer By : Health News
In a comprehensive review of breast cancer research, Britain's most influential breast cancer experts have identified the key loopholes in breast cancer treatment.......... - Women over 40 more prone to cervical cancer By : Health News
Women over 40, beware. Medical experts say you are more prone to cervical cancer and would do well not to ignore any kind of vaginal pain. - Pro-Pharmaceuticals Announces DAVANAT(R) Regimen Approved To Treat Breast Cancer Patient By : Health News
Pro-Pharmaceuticals, Inc. (Amex: PRW), announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of DAVANAT® in combination with chemotherapy and biologic to treat a breast cancer patient. - Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus By : Health News
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, announced an agreement with W. C. Heraeus GmbH for the commercial manufacture......... - Strengthening The Tumor-fighting Ability Of T Cells By : Health News
When faced with cancer, the immune system dispatches cells, called T cells, to kill the tumor. - Patient Reported Outcomes (PROs) Improve Cancer Treatment -- Experts Agree By : Health News
An information technology revolution is improving cancer treatment with the use of Patient-Reported Outcomes (PROs), according to Supportive Oncology Services, Inc. (SOS)......... - Tyverb (lapatinib) European Regulatory Update By : Health News
GlaxoSmithKline confirms that the EU Commission has referred Tyverb (lapatinib)....... - Grant Supplies Queensland Researchers With The Latest Tools To Fight Cancer By : Health News
University of Queensland researchers will be at the forefront of fighting cancer thanks to a new $3.2 million grant from the Australian Cancer Research Foundation (ACRF). - Treating Wife's Stress May Be Indirect Care For Men With Prostate Cancer By : Health News
When a couple is dealing with cancer, a partner's psychological distress might drag down the well-being of either person, according to a new study of 168 married couples. - Biomagnetics Developed For Use In New Breast Cancer Test By : Health News
A team from UCL has developed a new medical device which will make the early detection of breast cancer more cost effective and easier to administer. - FDA Clears Cellsearch™ Circulating Tumor Cell Test For Monitoring Metastatic Prostate Cancer By : Health News
Veridex, LLC announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch™ System.......... - Anadys Pharmaceuticals Commences Phase I Clinical Trial Of ANA773 In Cancer Patients By : Health News
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced that patient dosing has commenced in a Phase I study of ANA773, the company's oral TLR7 agonist prodrug, in patients with advanced solid tumors. - Center For Molecular Medicine Among First To Offer New FDA Approved Test To Aid In Treatment By : Health News
The Center for Molecular Medicine (CMM) announced it is one of the first laboratories in the nation to offer a new, FDA-approved test that will aid in the treatment of metastatic prostate cancer. - Transcriptional Factors And Regulators By : Stephen Jones
All the cellular processes in living cells such as growth, development, morphogenesis and cellular differentiation are a product of gene expression programs involving complicated transcriptional regulation of several genes. This process of transcriptional regulation is tightly controlled and coordinated by proteins called transcriptional regulators. - Toll-Like Receptor(TLR) : Unique Antibody from Imgenex By : Stephen Jones
Toll-like Receptor (TLR) family is a phylogenetically conserved mediator of innate immunity that is essential for microbial recognition. TLRs are evolutionarily conserved and their congeners have been found in insects, plants, and mammals. - Data Validation through Tissue Analysis By : Stephen Jones
IMGENEX History-Array tissue array slides are a simple, powerful, inexpensive, yet highly efficient method for expression analysis or localization studies of molecular targets at the DNA, RNA or protein level. - Improved RNA interference kits launched by Imgenex By : Stephen Jones
RNA interference (RNAi) is the process of mRNA degradation that is induced by double-stranded RNA in a sequence-specific manner. RNAi has been observed in all eukaryotes, from yeast to mammals. The RNAi pathway is thought to be an ancient mechanism for protecting the host and its genome against viruses and rogue genetic elements that use double-stranded RNA (dsRNA) in their life cycles. - Regulatory T Cells (Treg) By : Stephen Jones
Early development and differentiation of nascent T cells inside the thymus is a complex and remarkable mechanism.These types of T-cells require a different strategy to tame their autoimmune potential. One of many immunotolerance mechanisms that immune system has developed to distinguish between self and non-self antigens is regulatory T cells or Tregs. - NF-kB Activation: Elucidating Upstream Events By : Stephen Jones
NF-kB (Nuclear Factor-KappaB) is a heterodimeric protein composed of different combinations of members of the Rel family of transcription factors. The Rel/NF-kB family of transcription factors are involved mainly in stress-induced, immune, and inflammatory responses. - GPCRs: Exploring New Paradigms By : Stephen Jones
As one of the largest and most diverse protein families in nature, the G-protein coupled receptor (GPCR) superfamily play important roles in a variety of biological and pathological processes such as development and proliferation, neuromodulation, angiogenesis, metabolic disorders, inflammation, and viral infection. Not surprisingly, it is one of the most targeted protein families in pharmaceutical research today(Schlyer 2006). - Fundamental Immunology, Basic Immunology and Allergy Immunology By : Stephen Jones
Immunology is a broad branch of biomedical science that covers the study of all aspects of the immune system in all organisms. The immune system is the body's defense against infectious organisms and other invaders. Through a series of steps called the immune response, the immune system attacks organisms and substances that invade our systems and cause disease. - New FOXP3Δ2 (Exon 2 Deleted) Specific Antibody By : Stephen Jones
FOXP3 is a master regulator of immune homeostasis expressed specifically in CD4+ CD25+ T regulatory cells controlling their growth, development and function and generally accepted to be expressed in both mouse and human CD4+ CD25+ regulatory T cells. - GPR83: A Novel Treg Expressed Cell Surface Marker By : Stephen Jones
GPR83 is a member of the Orphan-A G-Protein coupled receptor family, and has anunknown ligand. It has been previously reported in various regions of the brain, within a subset of T-lymphocytes, and by RT-PCR at low levels in heart, kidney, liver, and otherorgans. - Faces of DARPP-32: Master Signaling Mediator in the Brain? By : Stephen Jones
As a major target for dopamine-activated adenylyl cyclase and protein kinase A in the striatum, DARPP-32 plays a central role in regulating the efficacy of dopaminergic neurotransmission and can act either as a phosphatase or kinase inhibitor in a contextually dependent manner. - Epigenetic and Signal Transduction Reagents By : Stephen Jones
IMGENEX offers over 90 Chromatin, DNA Methylation & Repair, and DNA Fragmentation-related antibodies, many of which have been cited in numerous peer-reviewed journals. - QuikChIP Chromatin Immunoprecipitation Kits By : Stephen Jones
The principle of the ChIP assay is simple yet the process can be technically challenging. It is with these challenges in mind that IMGENEX developed the QuikChIP Kit for chromatin immunoprecipitation. - ATM (Ataxia Telangiectasia Mutated) Antibodies from Imgenex By : Stephen Jones
ATM, the gene product mutated in the cancer susceptibility syndrome ataxia–telangiectasia, is related to proteins involved in DNA repair and cell-cycle control. In undamaged cells it is present as a dimer or oligomer molecule in which the kinase domain is silent because associated with the FAT region of another ATM monomer. - Are we "Livin" or just "Survivin"? By : Stephen Jones
Apoptosis is regulated by death domain (DD) and/or caspase recruitment domain (CARD) containing molecules and a caspase family of proteases. A novel CARD domain containing protein was recently identified and designated ARC for apoptosis repressor with CARD (1). - Apoptosis Programmed Cell Death By : Stephen Jones
Apoptosis is regulated by death domain (DD) and/or caspase recruitment domain (CARD) containing molecules and a caspase family of proteases. A novel CARD domain containing protein was recently identified and designated ARC for apoptosis repressor with CARD (1). - Akt Family: Antibodies from Imgenex By : Stephen Jones
Akt family of serine/threonine-directed kinases regulates a diverse array of biological processes, including cellular survival, proliferation, glucose homeostasis, and vascular tone and are important molecules in mammalian cellular signaling. - Actin Antibody Available in Imgenex now By : Stephen Jones
Actin is a ubiquitous protein involved in the formation of filaments that are major components of the cytoskeleton. It is the monomeric subunit of microfilaments, one of the three major components of the cytoskeleton, and of thin filaments which are part of the contractile apparatus in muscle cells. - Breast Cancer Subtypes Linked To Survival From Secondary Brain Tumors By : Health News
Screening breast cancers for three receptors could help doctors predict the likely survival of patients with brain metastases. - New Blood Marker May Predict Prostate Cancer Spread By : Health News
Researchers report finding a new blood biomarker that enables close to 98 percent accuracy in predicting the spread of prostate cancer to regional lymph nodes. - New Blood Marker May Predict Prostate Cancer Spread By : Health News
Researchers report finding a new blood biomarker that enables close to 98 percent accuracy in predicting the spread of prostate cancer to regional lymph nodes. - New Blood Marker May Predict Prostate Cancer Spread By : Health News
Researchers report finding a new blood biomarker that enables close to 98 percent accuracy in predicting the spread of prostate cancer to regional lymph nodes. - Pin Point Radiotherapy Procedure Proved Success For Breast Cancer By : Health News
A large scale trial conducted at the European Institute of Oncology (IEO) in Milan has proved a novel radiotherapy procedure to be a great success both in terms of medical results and cost effectiveness. - IRIS International Announces Successful Completion Of Retrospective Study Of 85 Post-Prostatectomy By : Health News
Iris International, Inc. announced that its Iris Molecular Diagnostics (IMD) group has successfully completed a retrospective study of stored leftover serum of 85 post-prostatectomy patients.......... - FDA Clears Cellsearch(TM) Circulating Tumor Cell Test For Monitoring Metastatic Prostate Cancer By : Health News
Veridex, LLC announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch(TM) System........... - Egyptian Children's Cancer Hospital Foundation Selects Cerner Technology To Improve Care For Patient By : Health News
The Children's Cancer Hospital Foundation 57357 (CCHF) in Egypt announced that it has selected Cerner Corporation (NASDAQ:CERN) as the healthcare information technology (HIT) provider for Children's Cancer Hospital Egypt 57357. - NCGR Software Enables Identification Of Mutated Genes Unique To Mesothelioma Tumors By : Health News
The National Center for Genome Resources (NCGR) announced the launch of the first web-based software system specifically designed for analysis of ultra-high throughput DNA sequencing projects. - Rexahn Awarded Maryland Industrial Partnerships Grant To Develop Polymer-Drug Conjugates By : Health News
Rexahn Pharmaceuticals, Inc. (OTC BB: RXHN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer........... - Treatment Of First Patient In Phase I Clinical Trial Of Bionomics' Anti-Cancer Drug BNC105 By : Health News
Bionomics Limited (ASX: BNO) announced the initiation of treatment for the first patient in the Phase I trial of its anti-cancer drug, BNC105. - Study Supports 'Decision Aids' For Men Considering Prostate Test By : Health News
Healthy middle-aged men who watch extensive online presentations about prostate cancer are more likely to understand the disease than those who simply visit health Web sites, according to a new study. - New Bladder Cancer Therapy For Patients Unresponsive To Standard Treatment By : Health News
As many as half of patients with superficial bladder cancer do not respond to the standard first-line chemotherapy placed into the bladder, according to current multi-center outcomes data. - Homeless Women Get Mammograms At Project Homeless Connect By : Health News
For women who lack a home or a safe place to stay, getting a regular mammogram is probably way down on their list of things to do. - High Zinc Status In Lung Cells Slows Growth And Induces DNA Damage-Induced Gene Expression By : Health News
Researchers at the University of Maryland at College Park have discovered that Normal Human Bronchial Epithelial (NHBE) cells cultured in medium with elevated zinc level.......... - Breast Cancer Action Disagrees With FDA's Avastin Ruling By : Health News
Breast Cancer Action (BCA) strongly disagrees with the Food and Drug Administration's decision giving accelerated approval to biotech company Genentech's application to market its drug.......... - LA BioMed Research Finds Combined Hormone Therapy Can Increase Frequency Of Abnormal Mammograms By : Health News
Combined hormone therapy appears to increase the risk that women will have abnormal mammograms and breast biopsies.......... - Three Year Analysis Of Treatment Efficacy, Cosmesis, And Toxicity Support Use Of The Hologic By : Health News
Hologic, Inc. a diversified medical technologies company specializing in imaging systems........... - 'Enormous Progress' In Reducing Cancer Does Not Include Lung Cancer By : Health News
Lung Cancer Alliance (LCA) cautioned that recently released cancer statistics indicate that lung cancer continues to kill more people each year than all the other major cancers combined. - Announcement Of National Lung Cancer Partnership By : Health News
The National Lung Cancer Partnership has announced that they are joining three distinguished organizations: the Lance Armstrong Foundation.......... - Cumulative Association Of Five Genetic Variants With Prostate Cancer By : Health News
UroToday.com - In addition to age, race, and a positive family history it is now known that variants in chromosomal regions............. - Nymox's NX-1207 Offers A New And Attractive Approach To The Treatment Of Benign Prostatic By : Health News
Nymox Pharmaceutical Corporation provided an outline of the outstanding potential the Company's proprietary drug........ - Pre Clinical Data Show Intracellular Pathways Affected By ONCONASE(R) By : Health News
Alfacell Corporation (Nasdaq: ACEL) announced that in vitro and in vivo data presented at the 5th Cancer Drug Research & Development conference show the genes affected............... - Contribution Of Cancer Care Nurses Hard To Gauge By : Health News
In the United States and in other high-income countries, women diagnosed with breast cancer are commonly matched with a specialist cancer nurse who provides care.......... - Mercy Only Hospital In Baltimore Metro Area To Participate In Study Re: New Option For Advanced By : Health News
Noted surgical oncologist Dr. Armando Sardi, Director, The Institute for Cancer Care at Mercy Medical Center........... - InNexus Biotechnology Announces Second Preclinical CandidateDXL702 (HER2/neu) By : Health News
InNexus Biotechnology Inc., a drug development company commercializing the next generation of monoclonal antibodies based on its technology, Dynamic Cross Linking (DXL™), announced that it has released its second candidate into preclinical status, DXL702 (HER2/neu), for the treatment of breast cancer. - The Race Is On: Pharmaceutical Companies Compete To Develop Less Toxic More Efficacious By : Health News
The Pharmaceutical / Biotechnology Group at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the targeted therapies segment of U.S.......... - Inclusion Of Six-Year Overall Survival Data In The Eloxatin(R) (oxaliplatin Injection) By : Health News
Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and assigned priority review status to a supplemental new drug application (sNDA) that proposes............ - Varian Medical Systems Announces Symposia On RapidArc Technology For Faster By : Health News
Varian Medical Systems (NYSE: VAR) is announcing a series of educational symposia about its revolutionary RapidArc(TM) radiotherapy technology for faster and more precise cancer treatments. - U.S. Cancer Deaths Down But Far Too Few Americans Screened For Colon Cancer By : Health News
New data revealing decreasing trends in cancer deaths in the United States overall, and in colorectal cancer deaths in particular............ - Vitamin Pills And Cancer Patients By : Health News
A study has claimed that "cancer patients who use vitamin and mineral supplements could risk them interfering with treatment or even making the disease worse", the Daily Mail reported . - New Method For Detecting HER2 Breast Cancer By : Health News
Generations of mothers have served up chicken soup to remedy the common cold, but now the therapeutic fowl may find use in diagnosis as well. - Lower PSA Values Found In Overweight And Obese Men, Even Before Diagnosis Of Prostate Cancer By : Health News
Men who are overweight or obese have lower concentrations of prostate-specific antigen (PSA) in their blood than their normal-weight counterparts, according to a new study led by Duke University Medical Center researchers. - Hormone Refractory Prostate Cancers More Likely To Spread To Other Organs By : Health News
Prostate cancers that are resistant to androgen deprivation therapy are more invasive and more likely to spread to other organs than androgen dependent prostate cancers, UCLA cancer researchers have found. - Vaccine/Antibody Therapy Effective In Melanoma And Ovarian Cancer By : Health News
One of the shortcomings of a therapy that uses millions of identical antibodies to boost the immune system's attack on cancer cells is that many patients whose tumors recede in response to the treatment also experience serious inflammatory problems, such as severe diarrhea and rashes. - ASCO GU 2008 - Androgen Suppression And Radiation Versus Radiation For Prostate Cancer By : Health News
UroToday.com - This study sought to compare survival in a prospective randomized trial of radiotherapy (XRT) alone vs. XRT with 6 months of ADT. - Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates A Phase 2b Metastatic By : Health News
Accelerated Community Oncology Research Network, Inc. (ACORN), announced the initiation of a Phase 2b clinical trial evaluating the efficacy of Nexavar(R) (sorafenib) tablets in combination.......... - The Facts African Americans Need To Know About Colon Cancer By : Health News
Each year more than 150,000 people in the United States are diagnosed with colon cancer and over 50,000 will die from the disease. - Single Reader With CAD More Efficient, Yields Fewer False Positives, And Possibly More Sensitive By : Health News
Single reading of screening mammograms with computer-aided detection (CAD) is more efficient than double reading and yields a higher sensitivity than the first reader in a double reading program............ - Benefits Of Medicare Paid Mammography Lag For Black Women By : Health News
When Medicare began paying for older women to undergo preventive mammograms in 1991, doctors expected breast cancer mortality rates to drop. - Hair Stylists Promote Breast Cancer Prevention Messages To Clients By : Health News
Authors of a Brooklyn, N.Y., study say hair stylists might be a good resource for both healthy hair and information on breast cancer prevention. - First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) By : Health News
On Thursday, January 31, General Hospital Vienna successfully completed its first Volumetric Modulated Arc Therapy (VMAT) treatment. - Preliminary PI-88 Phase 2 Prostate Cancer Results To Be Presented At The American Society By : Health News
Progen Pharmaceuticals Limited announced positive preliminary efficacy results from a phase 2 investigator-initiated trial of PI-88 in combination with the chemotherapeutic agent Taxotere(R) (docetaxel) administered to patients with prostate cancer. - Raven Announces Completion Of Enrollment In The Phase 1/2a Clinical Trial Of RAV12 Therapeutic By : Health News
Raven biotechnologies, inc., a privately held company focused on the development of monoclonal antibody therapeutics (MAbs) for cancer............ - Second Phase III Study Of Avastin In 1st Line Metastatic Breast Cancer Meets Its Primary Endpoint By : Health News
Roche announced that a phase III study in metastatic breast cancer investigating Avastin (bevacizumab) in combination with docetaxel chemotherapy compared to docetaxel alone............ - GPS For The Prostate: System Keeps Radiation Therapy On Target By : Health News
A system for tracking the movement of the prostate during radiation therapy has gone into service at the Seattle Cancer Care Alliance. - Scientists Solve Structure Of Gene Regulator That Plays Key Role In Cancer By : Health News
Scientists at The Wistar Institute have collaborated on a major advance in understanding a gene regulator that contributes to some of the deadliest cancers in humans. - Poultry Virus As Human Cancer Treatment By : Health News
Researchers on the Blacksburg and College Park, Md., campuses of the Virginia-Maryland Regional College of Veterinary Medicine............. - HPV-positive Head And Neck Cancer Patients Fare Better Than HPV-negative Patients By : Health News
Head and neck cancer patients with HPV-positive tumors tend to survive longer and are more responsive to treatment compared with patients with HPV-negative tumors, according to a study published online February 12 in the Journal of the National Cancer Institute. - Peregrine Pharmaceuticals Doses First Patient In Phase II Clinical Trial Of Bavituximab In Patients By : Health News
Peregrine Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing targeted therapies for the treatment of cancer and hepatitis C virus infection (HCV)........... - Anxiety Tied To DCIS Patients' Overestimation Of Cancer Risks By : Health News
Elevated levels of anxiety may cause women with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer, to overestimate their risk of recurrence or dying from breast cancer, suggests a study led by researchers at Dana-Farber Cancer Institute in Boston. - Breast Cancer Biomarkers Uncovered By : Health News
Breast cancer sufferers should benefit from the first major piece of research by the University of Essex's Proteomics Unit. - Cancer Pioneer Reaches Key Agreement On Colon Cancer Drug OncoVAX(R) By : Health News
Cancer research pioneer Michael G. Hanna Jr. Ph.D., also Vaccinogen, Inc.'s Founder, Chairman and CEO has acquired the rights to OncoVAX(R), a vaccine with the potential to prevent colon cancer from recurring in many patients. - AGA Medical Corporation Receives European CE Mark Approval For The AMPLATZER(R) Duct Occluder II By : Health News
The Society of Gynecologic Oncologists (SGO) will host its 39th Annual Meeting on Women's Cancer March 9-12 at the Tampa Convention Center in Tampa, Florida. - Benefit Of Cancer Prevention Surgery Differs Between Women With BRCA1 And BRCA2 Mutations By : Health News
The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. - UK Scientists Uncover Clue To Cancer Drug Resistance By : Health News
Scientists in London have discovered a new genetic mechanism which helps cancer cells survive by changing the way they respond to treatment. - Seven New Prostate Cancer Genetic Risk Factors Identified By : Health News
Cancer Research UK-funded scientists have found seven new sites in the human genome that are linked to men's risk of developing prostate cancer. Their findings are published in Nature Genetics* yesterday. - First European Lung Cancer Conference April 23-28 2008, Geneva, Switzerland By : Health News
Lung cancer is globally recognized as a big killer and it is undoubtedly a leading cause of cancer deaths in Europe and in the world. - Expression Pathology Obtains Maryland Funding To Develop Breast Cancer Test By : Health News
Expression Pathology Inc. (EPI), a leader in tissue protein analysis, has obtained $125,000 from the State of Maryland to develop a quantitative test for HER2 protein.......... - Sellion Inc. Launches 'EAT MY LIGNANS' Marketing Campaign By : Health News
Sellion Inc., producers of Imvia Natural products announced today the start of a new advertising and marketing campaign......... - Mole Or Melanoma? Natural Secretion Marks The Difference By : Health News
A protein naturally produced and secreted by the body can make the difference between your average mole and melanoma, which killed more than 8,000 people in the United States last year.......... - The Breast Cancer 3-Day: Coming to a Sidewalk Near You By : Health News
Communities nationwide will see thousands of people walking together when the Breast Cancer 3-Day returns to for its 2008 series. - Neuroscientists Offer Hope For Breast Cancer Patients Suffering From 'Chemobrain' By : Health News
Researchers will present data at the International Neuropsychological Society's annual meeting showing that training on the Posit Science(R) Brain Fitness Program(TM) improves mental function in cancer patients with "chemobrain". - ADVENTRX To Present Complete ANX-530 Pharmacokinetic Data At The 2008 American Association By : Health News
ADVENTRX Pharmaceuticals, Inc. (Amex: ANX), announced that complete pharmacokinetic data from the Company's marketing-enabling bioequivalence clinical study 2008 American Association............ - First Analysis Of The Long-Term Results With Transrectal HIFU In Patients With Localized By : Health News
UroToday.com- High-intensity focused ultrasound (HIFU) is gaining popularity as a potential new treatment for localized prostate cancer (CaP). - Nomogram Incorporating PSA Level To Predict Cancer-Specific Survival For Men With Clinically By : Health News
UroToday.com- In the online version of Cancer, Dr. Kattan and collaborators report an internally validated nomogram for predicting the probability that a man will survive his prostate cancer (CaP) if he does not have it treated immediately.
|
